Pharming Group is trading 5.4% down at €0.87, with the decline potentially reflecting the CEO’s immediate departure amid disagreement over strategy.
- On September 29, CEO Fabrice Chouraqui and the board agreed he would leave immediately, citing insufficient alignment on advancing the company’s strategy.
- The chief commercial officer and CFO were appointed interim co-CEOs as the board began a search for a permanent successor.
- Supplied market context showed no significant index move in the same direction; no verified volume information was found.